Idarubicin Hydrochloride Injection, Solution
Product Images NDC 71288-186

This is a description of a medication called Darubicin Hydrochloride Injection, USP. It comes in a 10 mg per 10 mL single-dose vial for intravenous use only. The solution is sterile and isotonic. The package insert should be consulted for the usual dosage. It is important to store the medication under refrigeration and protect it from light. The medication container does not contain natural rubber latex. Severe tissue reactions can occur if the medication is extravasated during administration.*

This is a description of a medication called IDArubicin Hydrochloride Injection. It is a cytotoxic agent intended for intravenous use only. The medication is provided in a single-dose vial containing 20 mL of sterile, isotonic solution. The warning mentions potential severe cellulitis, vesication, and tissue necrosis if the medication leaks outside the vein during administration. The product is non-pyrogenic and does not contain natural rubber latex in the container closure. The manufacturer is Meitheal Pharmaceuticals based in Chicago, USA.*

This is information about a medication named Idarubicin Hydrochloride Injection. It comes in a single-dose vial of 5mg per 5mL (1mg/mL) solution intended for intravenous use. The caution mentions it is a cytotoxic agent. Each mL contains 1mg of idarubicin hydrochloride, glycerin, and water for injection. The storage instructions advise refrigeration between 2° to 8°C and protection from light. The package insert should be consulted for the usual dosage. Special attention is given to avoiding extravasation during administration, which could cause local tissue damage. The medication is non-pyrogenic, and the container closure does not contain natural rubber latex. Manufacturer details indicate Meitheal Pharmaceuticals in Chicago, USA, and copyright ©2024 Meitheal Pharmaceuticals.*